McMillion Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
McMillion Capital Management's DGX Position: Q2 2023 in Review
McMillion Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2023 at 2,000 shares worth $281K. The position accounts for 0.25% of the portfolio, ranked #66.
McMillion Capital Management first reported a position in DGX in Q2 2017 and has held it in 21 quarters since. The position peaked at $346K in Q4 2021. 820 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- McMillion Capital Management held 2,000 shares of Quest Diagnostics worth $281K as of Q2 2023.
- McMillion Capital Management left its Quest Diagnostics share count unchanged in Q2 2023.
- Quest Diagnostics made up 0.25% of McMillion Capital Management's portfolio in Q2 2023, its #66 holding.
- McMillion Capital Management first reported a position in Quest Diagnostics in Q2 2017 and has held it in 21 quarters since.
- McMillion Capital Management's Quest Diagnostics position peaked at $346K in Q4 2021.
- 820 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.